A Cost-Effectiveness Analysis of Cisplatin Plus Pemetrexed Doublet Induction Treatment Followed by Pemetrexed Maintenance Compared with Bevacizumab Plus Cisplatin Plus Gemcitabine Triplet Induction Treatment Followed by Bevacizumab Maintena ...
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.499
https://www.valueinhealthjournal.com/article/S1098-3015(13)02404-2/fulltext
Title :
A Cost-Effectiveness Analysis of Cisplatin Plus Pemetrexed Doublet Induction Treatment Followed by Pemetrexed Maintenance Compared with Bevacizumab Plus Cisplatin Plus Gemcitabine Triplet Induction Treatment Followed by Bevacizumab Maintena ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02404-2&doi=10.1016/j.jval.2013.08.499
First page :
A410
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
480